Compensatory mechanism of meurohumoral factors in heart failure by 蔦本 尚慶 et al.
神経体液性因子における心不全の代償機序とその限
界


























65出AmericanHeart Association Sessions 
(1992.11.16・19，New Orleans Louisiana U.S.A.) 
Correlation between Endothelin・1Production in Pulmonary Circulation and the 
Pulmonary Vascular Resistance in Patients with αrronic Heart Failure 
Takayoshi Tsutamoto， Atsuyuki Wada， Masahiko Kinoshita 
(Circulalion 8.6:4 Suppl 1・50，1992)
66血AmericanHeart Association Sessions 
(1993.11.8・22，Atlanta Georgia U.S.A.) 
Plasma Brain Natriuretic Peptide Concentration as a Prognostic Predictor in 
Patients with Chronic Congestive Heart Failure 
Takayoshi Tsutamoto， Yukiharu Maeda， Atsuyuki Wada， Takako Adachi， 



















Uncoupling of Atrial Natriuretic Peptide Extraction and Cyclic Guanosine 
Monophospha旬 Productionin the Pulmonary Circulation in Patients with seve問
Heart Failure 
Takayoshi Tsutamoto， Toshiyuki Kanamori， Atsuyuki Wada， Masahiko Kinoshita 
J Am Coll Cardiol 20 3:541-546，1992 
Possibility of Downregulation of Atrial Natriuretic Peptide Receptor Coupled to 
Guany late Cyclase in Peripheral Vascular Beds of Patients with Chronic Severe 
Heart Failure 
Takayoshi Tsutamoto， Toshiyuki Kanamori， Naoki Morigami， Yoshihisa 
Sugimoto， Osamu Yamaoka， Masahiko Kinoshita 






慢性心不全で上昇する内因性心房性ナトリウム利尿ベプチド (AN P ) 
の代償機序は、軽症心不全では保持されているが、重症心不全患者では受
容体のダウンレギュレーションにより減弱していることを心不全患者で








て、 ANP濃度測定が non-i nvas i veな指標として育用であることを明
らかにした (Am Heart J， i n press)。
最近明らかになった脳性ナトリウム利尿ペプチド(B N P )濃度も制
定し、 ANP濃度と比較したその結果、心不全患者において、 B N Pの
方が ANPに比しより重症度を反映して上昇すること、さらに心不全患





Background. Plasma atrial natriuretic peptide concentrations in patients with 
heart failure have been reported to be higher血anthose in normal su同ectsand to 
increase as the severity of heart failure progresses. Although endogenous atrial 
natriuretic peptide is thought to improve the condition of patients with hean 
failure by reducing preload and afterload， recent findings have indicated血ata 
high plasma atrial natiruretic peptide level is a prognostic predictor in patients 
with heart failure. 
Methods and Results. To evaluate the pathophysiologic role of endogenous 
atrial natriuretic peptide in the pulmonary circulation， plasma atrial natriuretic 
peptide in血epulmonary circulation， plasma atrial natriuretic peptide and cyclic 
guanosine monophosphate (cGMP) levels were determined in the main pulmon句
artery and pulmonary capillary wedge region in 80 patients with chronic 
congestive heart failure (New York Heart Association functional classes I to IV). 
Results. The plasma atrial natriuretic peptide level decreased significantly from 
the main pulmonary a口eryto出epulmonary capillary wedge region， whereas the 
plasma cGMP level increased significantly from the main pulmonary artery to血e
pulmonary capillary wedge region. In patients with mild chronic heart failure 
(n=50)， the plasma atrial natriuretic peptide level correlated with the cGMP level 
in the main pulmonary artery (y =0.71， Pく0.001).The atrial natriuretic peptide 
extraction level， calculated as (calculated as (Atrial natriuretic peptide in the main 
pulmonary artery -Atrial natriuretic peptide in the pulmonary capillary wedge 
region) >くCardiacoutputX (1・hematocrit/100)(ng/min)，also correlated with the 
cyclic guanosine monophosphate production level， calculated as (cGMP in血e
pulmonary capillary wedge region -cGMP in the main pulmonary artery)X 
Cardiac outputX (l-hematocrit/100)(nmol/min)( y =0.78， Pく0.001).In contrast， 
such correlations were not found in patients with severe chronic heart 
failure(n=30). In those patients， the atrial natriuretic peptide extraction level w出
significantly higher but there was no significant difference in the cG:MP 
production level between the two groups (mild and severe chronic heart failure). 
Therefore， the molar ratio of cGMP production to atrial natriuretic peptide 
extraction in the pulmonary circulation was significantly lower in patients with 
severe chronic heart failure (88+ 16 vs. 480+41， Pく0.001). Moreover the 
plasma ANP and cGMP levels were determined in the femoral artery and白e
femoral vein of 97 patients with chronic congestive heart failure (CHF).明記
plasma ANP level decreased significantly， whereas the plasma cGMP levels 
increased significantly from the femoral artery to the femoral vein. Among 
patients with mild CHF (n=52)， the plasma cGMP level correlated with the ANP 
level， and the calculated ANP extraction level also correlated with the calculated 
cGMP production in the peripheral circulation (r=0.70， p<O.OOI). In contrast， 
these correlations were not found in patients with severe CHF (n=45). Among 
these patients， the plasma cGMP levels seemed to reach a plateau despite high 
levels of plasma ANP， and the molar ratio of cGMP production to ANP extraction 
in the peripheral circulation was significantly lower血anin patients with mild 
CHF (36.7 + 9.5 versus 183 + 17， Pく0.001). In patients with acu旬 severeαE
(n=9) and those with mild CHF， patients who were administered exogenous ANP， 
plasma cGMP levels increased in proportion to those of plasma ANP without 
saturatlOn. 
Conclusions. These results indicate that down-regulation of atrial natriuretic 
peptide receptors coupled to guanylate cyclase may occur not only in血e
pulmonary vascular beds but also peripheral vascular beds of patien臼withsevere 
chronic heart failure. 
